Atrial fibrillation: a risk factor or risk marker?

Suppr

超能文献

作者信息

Bunch T Jared, May Heidi T

机构信息

Intermountain Medical Center Heart Institute, Intermountain Medical Center, Murray, UT, USA

Stanford University, Department of Internal Medicine, Palo Alto, CA, USA.

出版信息

Eur Heart J. 2016 Oct 7;37(38):2890-2892. doi: 10.1093/eurheartj/ehw313. Epub 2016 Jul 19.

DOI:10.1093/eurheartj/ehw313

PMID:27436866

Abstract

摘要

相似文献

Atrial fibrillation: a risk factor or risk marker?

Eur Heart J. 2016 Oct 7;37(38):2890-2892. doi: 10.1093/eurheartj/ehw313. Epub 2016 Jul 19.

[Atrial fibrillation: Thromboembolic risk factor or marker? From concept to therapy].

Presse Med. 2017 Jul-Aug;46(7-8 Pt 1):751-757. doi: 10.1016/j.lpm.2017.06.013. Epub 2017 Jul 27.

Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?

J Thromb Thrombolysis. 2003 Dec;16(3):155-61. doi: 10.1023/B:THRO.0000024053.45693.fc.

Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting?

Ann Thorac Surg. 2004 May;77(5):1514-22; discussion 1522-4. doi: 10.1016/j.athoracsur.2003.09.069.

Typical atrial flutter ablation and the risk of postablation atrial fibrillation.

Ital Heart J. 2005 Dec;6(12):946-9.

The influence of age on atrial fibrillation as a risk factor for stroke.

Clin Exp Neurol. 1991;28:37-42.

[Atrial fibrillation--thromboembolism and prevention].

Ugeskr Laeger. 1991 Jul 22;153(30):2105-7.

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Circulation. 2014 Nov 18;130(21):1847-58. doi: 10.1161/CIRCULATIONAHA.114.011204. Epub 2014 Oct 7.

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.

JAMA. 2013 Nov 20;310(19):2050-60. doi: 10.1001/jama.2013.280521.

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.

Circulation. 2013 Jan 15;127(2):224-32. doi: 10.1161/CIRCULATIONAHA.112.107128. Epub 2012 Dec 3.

引用本文的文献

Risk of Death From Various Causes According to Prevalent Atrial Fibrillation: A Nationwide Population-Based Study.

J Korean Med Sci. 2024 Dec 9;39(47):e306. doi: 10.3346/jkms.2024.39.e306.

The higher recurrence rate after catheter ablation in younger patients with atrial fibrillation suggesting different pathophysiology.

J Interv Card Electrophysiol. 2023 Oct;66(7):1609-1619. doi: 10.1007/s10840-022-01461-0. Epub 2023 Jan 17.

Atrial high-rate episodes: a comprehensive review.

Cardiovasc J Afr. 2021;32(2):102-107. doi: 10.5830/CVJA-2020-052. Epub 2021 Jan 15.

The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation Outcomes.

J Atr Fibrillation. 2019 Apr 30;11(6):2164. doi: 10.4022/jafib.2164. eCollection 2019 Apr.

Improving CHADS-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation.

Open Heart. 2018 Nov 17;5(2):e000907. doi: 10.1136/openhrt-2018-000907. eCollection 2018.

Is left atrial appendage isolation a pyrrhic victory in the effort to treat atrial fibrillation?

J Thorac Dis. 2017 Jan;9(1):1-4. doi: 10.21037/jtd.2017.01.01.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验